Is read-across for chemicals comparable to medical device equivalence and where to use it for conformity assessment?
Regul Toxicol Pharmacol
; 149: 105622, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38588771
ABSTRACT
Novel medical devices must conform to medical device regulation (MDR) for European market entry. Likewise, chemicals must comply with the Registration, Evaluation, Authorization and Restriction of Chemicals (REACh) regulation. Both pose regulatory challenges for manufacturers, but concordantly provide an approach for transferring data from an already registered device or compound to the one undergoing accreditation. This is called equivalence for medical devices and read-across for chemicals. Although read-across is not explicitly prohibited in the process of medical device accreditation, it is usually not performed due to a lack of guidance and acceptance criteria from the authorities. Nonetheless, a scientifically justified read-across of material-based endpoints, as well as toxicological assessment of chemical aspects, such as extractables and leachables, can prevent failure of MDR device equivalence if data is lacking. Further, read-across, if applied correctly can facilitate the standard MDR conformity assessment. The need for read-across within medical device registration should let authorities to reconsider device accreditation and the formulation of respective guidance documents. Acceptance criteria like in the European Chemicals Agency (ECHA) read-across assessment framework (RAAF) are needed. This can reduce the impact of the MDR and help with keeping high European innovation device rate, beneficial for medical device patients.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Equipos y Suministros
Límite:
Animals
/
Humans
País como asunto:
Europa
Idioma:
En
Año:
2024
Tipo del documento:
Article